PMHSOTCPharmaceutical PreparationsFiscal year ends December 31

Polomar Health Services, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.12−0.01 (-4.00%)

Close on Oct 19, 2026

Market cap: $3.37M
P/E (TTM): –
Dividend yield: –

Polomar Health Services, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Depreciation & Amortization	9.77	0.26	0.01	–
Stock-Based Compensation	0.13	–	–	0.17
Change in Accounts Receivable	-0.10	0.00	0.03	-0.03
Change in Inventory	-0.02	-0.07	–	–
Change in Accounts Payable	0.22	0.13	0.03	0.00
Change in Unearned Revenue	0.30	–	–	–
Operating Cash Flow	-0.40	-1.02	-0.53	-0.04
Capital Expenditures	–	-0.09	–	–
Investing Cash Flow	–	-0.09	–	–
Stock Issued	–	–	0.22	0.23
Financing Cash Flow	0.52	1.11	0.32	0.27
Net Change in Cash	0.13	0.00	-0.22	0.23
Free Cash Flow	–	-1.11	–	–
Interest Paid	0.15	0.04	0.00	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 61.1%
Operating margin: -295.0%
Net margin: -298.3%
Return on equity, FY2025: -290.1%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: 1.06
Price to book: –
Dividend yield: –